Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.68 USD | +0.18% | -2.34% | -10.72% |
05:18pm | Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer | MT |
03:27pm | A flurry of corporate results ahead of the Fed's rate decision |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.72% | 145B | |
+32.56% | 664B | |
+29.29% | 567B | |
-7.05% | 354B | |
+19.72% | 330B | |
+4.87% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.80% | 148B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- SVB Leerink Adjusts Pfizer's Price Target to $48 from $50, Keeps Market Perform Rating